e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients
R. Plywaczewski, P. Bielen, L. Jonczak, D. Gorecka, P. Sliwinski (Warsaw, Poland)
Source:
Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Session:
Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Session type:
Thematic Poster Session
Number:
2234
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Plywaczewski, P. Bielen, L. Jonczak, D. Gorecka, P. Sliwinski (Warsaw, Poland). Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients. Eur Respir J 2011; 38: Suppl. 55, 2234
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 573s
Year: 2006
Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome
Source: Eur Respir J 2003; 22: 156-160
Year: 2003
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults?
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004
Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Source: Eur Respir Rev 2007; 16: 196-202
Year: 2007
Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002
Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT)
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Impaired glucose tolerance in obstructive sleep apnoea (OSA) patients – Results of oral glucose tolerance test (OGTT)
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Cardiovascular and metabolic effects of CPAP in obese males with OSA
Source: Eur Respir J 2007; 29: 720-727
Year: 2007
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept